You must have the latest - Flash plugin - to view this slideshow. 63-year history of research and clinical excellence

Disparities in outcomes for children with rare eye cancer suggest unequal access to primary care

October 05, 2015

Disparities in outcomes for children with retinoblastoma — a rare eye tumor usually discovered in routine pediatric check-ups — suggest unequal access to primary care, researchers from Dana-Farber/Boston Children’s Cancer and Blood Disorders Center report in a study published in the journal JAMA Pediatrics. Although virtually all the children in the study survived, Hispanic children and children who lived in disadvantaged areas were more likely to lose an eye due to late diagnosis.

Discover Care Believe - boy on pier

"Discover. Care. Believe." highlights Dana-Farber breakthroughs

Dana-Farber Cancer Institute has launched, a new platform to illustrate what sets Dana-Farber apart — in research discovery... in expert, compassionate care... and in our strong belief in progress for people with cancer everywhere.

What do you #DiscoverCareBelieve?


New Online Resource for Precision Cancer Medicine

Clinicians at Dana-Farber/Brigham and Women's Cancer Center are now armed with specialized tests to create a precise "tumor profile" for each patient's cancer. Learn about the latest thinking in precision cancer medicine from our researchers and clinicians, and explore a searchable database of clinical trials that focus on targeted therapies by disease, gene, and mutation.

Dana-Farber asserts joint inventorship on cancer immunotherapy patents
October 01, 2015

Dana-Farber is petitioning a federal court to determine that one of its scientists, Gordon Freeman, PhD, and another researcher are co-inventors on a series of cancer immunotherapy patents previously issued to a Japanese researcher and Japanese drug company.

Scientists target molecular 'addiction' in triple-negative breast cancer
September 28, 2015

Drugs that inhibit CDK7 may be a new therapy for treating triple-negative breast cancer.

New drug improves outcome in treatment resistant kidney cancer
September 25, 2015

A new drug for renal cell carcinoma slowed the growth of advanced kidney cancer in patients who became resistant to the first-line therapies that had previously kept it in check, according to results from a clinical trial led by Dana-Farber Cancer Institute.

Researchers develop strategy for determining how non-coding sequences contribute to disease risk
September 24, 2015

Dana-Farber scientists and colleagues use genome- and epigenome-editing tools to pinpoint disease-causing variants.

What Non-Smokers Need To Know About Lung Cancer (The Huffington Post)

October 06, 2015

Dr. Pasi A. Jänne commented about the rise in women in the United States being diagnosed with lung cancer who never smoked cigarettes.

Study: Angelina Jolie breast cancer battle increased surgery awareness (WHDH-TV 7)
October 05, 2015

In a new study, Dr. Judy Garber credits actress Angelina Jolie’s battle with breast cancer for increasing public awareness of breast cancer surgery options.


Why Doctors Are Rethinking Breast-Cancer Treatment (Time Magazine)
October 02, 2015

Dr. Mehra Golshan and Dr. Eric Winer commented on why doctors are calling for a change in the way they treat certain breast cancers.

A New Effort Has Doctors Turn Patients Into Donors (New York Times)
September 30, 2015

Dr. Edward J. Benz, Jr., commented on Dana-Farber’s policy not to involve physicians in a patient’s decision to become a financial donor.

Report: Greater Lowell cancer rates higher than statewide (Lowell Sun)
September 28, 2015

Dr. Christopher Lathan commented on a study that found residents in Greater Lowell have higher cancer rates than the rest of the state, with the highest rates among poorer residents.

Senate OKs bill barring teens under 18 from tanning salons (
September 25, 2015

The Massachusetts Senate unanimously passed a bill that would bar anyone under age 18 from using tanning beds. During a public hearing, Dr. Jennifer Lin said Dana-Farber sees 10 to 20 new cases of melanoma each week.

Two Boston Hospitals Are Studying Aspirin’s Effects on Breast Cancer (
September 24, 2015

Dana-Farber/Brigham and Women’s Cancer Center researchers were granted a $10 million award from the Department of Defense to conduct research to determine if a daily aspirin regimen is beneficial to cancer patients.

Boston hospitals to bring cancer treatments to Bermuda (Boston Business Journal)
September 18, 2015

Dr. Daphne Haas-Kogan commented on Dana-Farber/Brigham and Women’s Cancer Center’s recent agreement with Bermuda Cancer and Health Center to bring radiation therapy and experts in radiation to patients in Bermuda.

Gentle Hatha Yoga

October 07, 2015

10:00 AM - 10:45 AM

Smith Building, Room 330

This gentle Hatha Yoga class is open to patients, families and friends that have been newly diagnosed with cancer, receiving treatment, or in remission. Instructor, Ann Marie Turo will guide you in gentle stretches and breathing techniques that will calm you and leave you feeling refreshed and relaxed. Classes are complimentary and yoga mats are provided. Please contact the Zakim Center to register at 617-632-3322 or  


Drop-In Mediation - Wednesdays

October 07, 2015

10:00 AM - 10:45 AM

Smith Building, Room 335

Meditation is a mind-body practice that can help you relax and access a deeper awareness through connecting your mind, body and spirit. This forty-five minute class will help you learn a variety of meditation techniques, including breath and body focus, guided imagery and contemplation.


This class is open to patients who have been newly diagnosed with cancer, are receiving treatment, or are in remission. Family, friends, and staff are also welcome. 


Sessions are led by Patty Arcari, RN, PhD, Program Manager for Meditation and Mindfulness Programming, Zakim Center. Registration is recommended, but not required. Please contact the Zakim Center for more information at 617-632-3322 or email





October 07, 2015

11:00 AM - 12:00 PM

Smith Building, Room 330

This one-hour class fuses the practices of Hatha Yoga and Pilates and is open to patients who have been newly diagnosed with cancer, and receiving treatment, or are in remission. This class will work on building strength, endurance, and flexibility, while toning the deep core muscles. Yoga mats will be provided, or you may bring your own. Family, friends and staff are welcomePlease contact the Zakim Center to register at 617-632-3322 or  


Patients in active treatment will need medical clearance from their physician prior to registration.  


  • Patient referral information, clinical resources and more.

  • Make an Appointment

    For adults:

    Quick access: Appointments as soon as the next day for new adult patients

    For children:

    Request Appointment Online

  • Clinical Trials

    Search current cancer clinical trials at Dana-Farber.

  • How to Help

    Yawkey Center for Cancer Care entrance 

    There are many ways to support Dana-Farber and the Jimmy Fund.

    give now button
  • Top-ranked

    • U.S. News Best Hospitals Cancer 2015-2016 logo    U.S. News Best Children's Hospitals Cancer 2015-2016 logo 

    Top-ranked cancer center in New England for adults (with Brigham and Women's Hospital) — #1 in the nation for children (with Boston Children's Hospital)

  • Dana-Farber Blog

    Insight Blog screenshot

    Insight features the latest in cancer care and research news from Dana-Farber.
    Read the blog

  • Dana-Farber eNewsletter

    Dana-Farber Spotlight

    Stay current on the latest news by signing up for Spotlight, our email newsletter.
    View current issue
    Subscribe now